Quantra and ROTEM in Decompensated Cirrhosis: Method Comparison and Prognostic Value of Clot Time Ratio

BACKGROUND: Viscoelastic testing (VET) is increasingly used to assess coagulation abnormalities in patients with cirrhosis, yet cross-platform comparability and the clinical significance of VET parameters remain uncertain. This study compared analogous parameters across Quantra, ROTEM delta, and conventional coagulation tests (CCT) and examined associations with clinical outcomes in hospitalized patients with decompensated cirrhosis. METHODS: In this prospective observational study, hospitalized adults with decompensated cirrhosis underwent concurrent CCT, Quantra, and ROTEM delta testing. We assessed cross-platform associations and bias using weighted Deming regression. Prespecified VET parameters were evaluated for association with composite bleeding, thrombosis, and 30- and 90-day mortality. Because Quantra clot time ratio (CTR) was the only VET parameter associated with mortality, we further assessed its prognostic performance across severity scores, including Model for End-Stage Liver Disease 3.0 (MELD-3.0). RESULTS: Among 108 patients, comparable VET parameters showed strong-to-very strong correlations (r = 0.69-0.94), though we observed systematic bias between platforms. No parameters were associated with bleeding/thrombosis. CTR was associated with higher 30- and 90-day mortality; 90-day mortality was 35.7% with CTR > 1 vs. 18.8% with CTR ≤ 1. Adding CTR to MELD-3.0 showed the largest numerical increase in 90-day mortality discrimination (AUC 0.71 to 0.75), with smaller increases across other severity scores, though confidence intervals for change in AUC included zero for all models. CONCLUSION: Analogous Quantra and ROTEM showed strong-to-very strong correlations, although systematic differences limit their direct interchangeability. Exploratory analysis showed that Quantra CTR was associated with mortality, although further studies are needed to determine potential prognostic relevance.

Authors

Institutions

Publication Details

Journal
International Journal of Laboratory Hematology
Published
2026-11-17
DOI
https://doi.org/10.1111/ijlh.70284
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Quantra and ROTEM in Decompensated Cirrhosis: Method Comparison and Prognostic Value of Clot Time Ratio

Shannan R. Tujios, Christopher B. Webb, Sean G. Yates, Tanner Hardy et al.
International Journal of Laboratory Hematology
Liver Disease and Transplantation
article

Quantra and ROTEM in Decompensated Cirrhosis: Method Comparison and Prognostic Value of Clot Time Ratio

Shannan R. Tujios, Christopher B. Webb, Sean G. Yates, Tanner Hardy, Madhukar S. Patel, Daniel Welder, Arjmand Mufti, Ravi Sarode, Peiman Lahsaei
article en

Abstract

BACKGROUND: Viscoelastic testing (VET) is increasingly used to assess coagulation abnormalities in patients with cirrhosis, yet cross-platform comparability and the clinical significance of VET parameters remain uncertain. This study compared analogous parameters across Quantra, ROTEM delta, and conventional coagulation tests (CCT) and examined associations with clinical outcomes in hospitalized patients with decompensated cirrhosis. METHODS: In this prospective observational study, hospitalized adults with decompensated cirrhosis underwent concurrent CCT, Quantra, and ROTEM delta testing. We assessed cross-platform associations and bias using weighted Deming regression. Prespecified VET parameters were evaluated for association with composite bleeding, thrombosis, and 30- and 90-day mortality. Because Quantra clot time ratio (CTR) was the only VET parameter associated with mortality, we further assessed its prognostic performance across severity scores, including Model for End-Stage Liver Disease 3.0 (MELD-3.0). RESULTS: Among 108 patients, comparable VET parameters showed strong-to-very strong correlations (r = 0.69-0.94), though we observed systematic bias between platforms. No parameters were associated with bleeding/thrombosis. CTR was associated with higher 30- and 90-day mortality; 90-day mortality was 35.7% with CTR > 1 vs. 18.8% with CTR ≤ 1. Adding CTR to MELD-3.0 showed the largest numerical increase in 90-day mortality discrimination (AUC 0.71 to 0.75), with smaller increases across other severity scores, though confidence intervals for change in AUC included zero for all models. CONCLUSION: Analogous Quantra and ROTEM showed strong-to-very strong correlations, although systematic differences limit their direct interchangeability. Exploratory analysis showed that Quantra CTR was associated with mortality, although further studies are needed to determine potential prognostic relevance.

International Journal of Laboratory Hematology
Indiana University Health (US), Indiana University – Purdue University Indianapolis (US), The University of Texas Southwestern Medical Center (US)
Good health and well-being
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon